Search research articles
Contact Us
Filters
Showing results (71-80 of 137) with videos related to
Page
of 14
Sort By:
Matrix (Stuttgart, Germany)
|
February 1, 1992
Establishment of a cell line from the EHS tumor: biosynthesis of basement membrane constituents and characterization of a hybrid proteoglycan containing heparan and chondroitin sulfate chains
K G Danielson, A Martinez-Hernandez, J R Hassell, et al.
The Journal of Biological Chemistry
|
March 7, 1998
Decorin activates the epidermal growth factor receptor and elevates cytosolic Ca2+ in A431 carcinoma cells
S Patel, M Santra, D J McQuillan, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
February 1, 1994
Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization
A D Murdoch, B Liu, R Schwarting, et al.
Molecular and Cellular Biochemistry
|
April 12, 1995
The proteoglycan perlecan is expressed in the erythroleukemia cell line K562 and is upregulated by sodium butyrate and phorbol ester
S Grässel, I R Cohen, A D Murdoch, et al.
The Journal of Biological Chemistry
|
October 4, 1996
Identification of a bimodal regulatory element encompassing a canonical AP-1 binding site in the proximal promoter region of the human decorin gene
A Mauviel, K Korang, M Santra, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 7, 2000
Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia
M A Nugent, H M Nugent, R V Iozzo, et al.
The Journal of Biological Chemistry
|
April 25, 1992
Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor
A D Murdoch, G R Dodge, I Cohen, et al.
The Journal of Biological Chemistry
|
January 20, 2001
Fibroblast growth factor-binding protein is a novel partner for perlecan protein core
M Mongiat, J Otto, R Oldershaw, et al.
The Journal of Clinical Investigation
|
March 1, 1992
Genetic linkage of type VII collagen (COL7A1) to dominant dystrophic epidermolysis bullosa in families with abnormal anchoring fibrils
M Ryynänen, J Ryynänen, S Sollberg, et al.
Blood
|
August 1, 1996
Antisense oligodeoxynucleotide combination therapy of primary chronic myelogenous leukemia blast crisis in SCID mice
T Skorski, M Nieborowska-Skorska, P Wlodarski, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 137) with videos related to
Sort By:
Page
of 14
Matrix (Stuttgart, Germany)
|
February 1, 1992
Establishment of a cell line from the EHS tumor: biosynthesis of basement membrane constituents and characterization of a hybrid proteoglycan containing heparan and chondroitin sulfate chains
K G Danielson, A Martinez-Hernandez, J R Hassell, et al.
The Journal of Biological Chemistry
|
March 7, 1998
Decorin activates the epidermal growth factor receptor and elevates cytosolic Ca2+ in A431 carcinoma cells
S Patel, M Santra, D J McQuillan, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
February 1, 1994
Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization
A D Murdoch, B Liu, R Schwarting, et al.
Molecular and Cellular Biochemistry
|
April 12, 1995
The proteoglycan perlecan is expressed in the erythroleukemia cell line K562 and is upregulated by sodium butyrate and phorbol ester
S Grässel, I R Cohen, A D Murdoch, et al.
The Journal of Biological Chemistry
|
October 4, 1996
Identification of a bimodal regulatory element encompassing a canonical AP-1 binding site in the proximal promoter region of the human decorin gene
A Mauviel, K Korang, M Santra, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 7, 2000
Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia
M A Nugent, H M Nugent, R V Iozzo, et al.
The Journal of Biological Chemistry
|
April 25, 1992
Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor
A D Murdoch, G R Dodge, I Cohen, et al.
The Journal of Biological Chemistry
|
January 20, 2001
Fibroblast growth factor-binding protein is a novel partner for perlecan protein core
M Mongiat, J Otto, R Oldershaw, et al.
The Journal of Clinical Investigation
|
March 1, 1992
Genetic linkage of type VII collagen (COL7A1) to dominant dystrophic epidermolysis bullosa in families with abnormal anchoring fibrils
M Ryynänen, J Ryynänen, S Sollberg, et al.
Blood
|
August 1, 1996
Antisense oligodeoxynucleotide combination therapy of primary chronic myelogenous leukemia blast crisis in SCID mice
T Skorski, M Nieborowska-Skorska, P Wlodarski, et al.
Page
of 14